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A B S T R A C T
Background: Ataxia Telangiectasia (A-T) is an inherited multisystem disorder with cerebellar neurodegeneration.
The relationships between imaging metrics of cerebellar health and neurological function across childhood in A-
T are unknown, but may be important for determining timing and impact of therapeutic interventions.
Purpose: To test the hypothesis that abnormalities of cerebellar structure, physiology and cellular health occur in
childhood A-T and correlate with neurological disability, we performed multiparametric cerebellar MRI and
establish associations with disease status in childhood A-T.
Methods: Prospective cross-sectional observational study. 22 young people (9 females / 13 males, age 6.6–17.8
years) with A-T and 24 matched healthy controls underwent 3-Tesla MRI with volumetric, diﬀusion and proton
spectroscopic acquisitions. Participants with A-T underwent structured neurological assessment, and expression
/ activity of ataxia-telangiectasia mutated (ATM) kinase were recorded.
Results: Ataxia-telangiectasia participants had cerebellar volume loss (fractional total cerebellar volume: 5.3%
vs 8.7%, P<0.0005, fractional 4th ventricular volumes: 0.19% vs 0.13%, P<0.0005), that progressed with age
(fractional cerebellar volumes, r = -0.66, P = 0.001), diﬀerent from the control group (t = -4.88, P < 0.0005).
The relationship between cerebellar volume and age was similar for A-T participants with absent ATM kinase
production and those producing non-functioning ATM kinase. Markers of cerebellar white matter injury were
elevated in ataxia-telangiectasia vs controls (apparent diﬀusion coeﬃcient: 0.89 × 10−3 mm2 s−1 vs
0.69 × 10−3 mm2 s−1, p < 0.0005) and correlated (age-corrected) with neurometabolite ratios indicating
impaired neuronal viability (N-acetylaspartate:creatine r= -0.70, P< 0.001); gliosis (inositol:creatine r= 0.50,
P = 0.018; combined glutamine/glutamate:creatine r = -0.55, P = 0.008) and increased myelin turnover
(choline:creatine r = 0.68, P < 0.001). Fractional 4th ventricular volume was the only variable retained in the
regression model predicting neurological function (adjusted r2 = 0.29, P = 0.015).
Conclusions: Quantitative MRI demonstrates cerebellar abnormalities in children with A-T, providing non-in-
vasive measures of progressive cerebellar injury and markers reﬂecting neurological status. These MRI metrics
may be of value in determining timing and impact of interventions aimed at altering the natural history of A-T.
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Summary Statement: Quantitative cerebellar MRI demonstrates progressive cerebellar volume loss and altered neurometabolites indicative of cerebellar injury in
children and young people with ataxia telangiectasia, providing potential non-invasive markers of disease status
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1. Introduction
Ataxia Telangiectasia (A-T) is an autosomal recessive condition as-
sociated with cutaneous telangiectasias, cerebellar neurodegeneration,
immunodeﬁciency, respiratory disease and increased cancer risk
(Rothblum-Oviatt et al., 2016). Defects in the A-T mutated (ATM) gene
lead to absent or defective production of ATM protein kinase with roles
in repair of double-stranded DNA breaks and regulating cellular re-
sponses to oxidative stress (Lavin, 2008; Ditch and Paull, 2012;
Chen et al., 2003). Patients with classical A-T have complete absence of
ATM protein or defective ATM protein with no detectable kinase ac-
tivity (Jackson et al., 2016). A-T patients who have defective ATM
protein with limited kinase activity have variant A-T, and typically have
milder clinical phenotype.
In classical A-T onset of clinical features occurs at median age 18
months (Devaney et al., 2017) but brain MRI scans early in the disease
are often subjectively normal. In older children structural imaging
studies (reviewed by Sahama et al. Sahama et al., (2014)) report cer-
ebellar atrophy. Although studies have utilised neuroimaging techni-
ques such as diﬀusion tensor imaging (Sahama et al., 2014, 2015),
functional MRI (Quarantelli et al., 2013), and magnetic resonance
spectroscopy (Lin et al., 2006; Wallis et al., 2007) to investigate brain
structure and function in A-T, existing studies have not examined re-
lationships between quantitative imaging ﬁndings and severity of
neurological status in A-T, or between imaging metrics and age across
childhood.
We aim to identify candidate imaging markers of cerebellar health
and neurological disability that can be used in future treatment trials in
A-T. We hypothesise that abnormalities of cerebellar structure, phy-
siology and cellular health occur in childhood A-T and correlate with
neurological disability. To test this hypothesis we use quantitative MRI
measures of cerebellar volume, tissue ultrastructural integrity (apparent
diﬀusion coeﬃcient, ADC), and metabolic markers of neuronal viability
(N-Acetyl Aspartate), cell turnover / myelin breakdown (choline), ex-
citatory neurotransmission (combined glutamine and glutamate, Glx)
and gliosis/glial activation (Inositol and Glx) from the Childhood A-T
Neuroimaging Assessment Project (CATNAP). We compare metrics
from children and teenagers with A-T to normally developing controls.
We explore associations between cerebellar volume, water diﬀusion
and spectroscopic measures, and perform multivariate regression ana-
lysis to identify a potential biomarker set for predicting neurological
status in childhood A-T.
2. Materials and methods
2.1. Setting and participant recruitment
We conducted a single centre cross-sectional observational study set
in the UK National Paediatric A-T clinic at the Nottingham Children's
Hospital, a regional paediatric neurosciences centre. The study was
approved by UK National Research Ethics Service (14/EM/1175).
Informed consent was obtained from participants aged 16 to 18 years,
and from parents/guardians of participants aged under 16 years.
Participants in the A-T group were recruited from the UK National
Paediatric A-T Clinic. Inclusion criteria: Conﬁrmed diagnosis of A-T,
aged 6–18 years. Exclusion criteria: Contra-indication to MRI, con-
current or previous cancer or cancer treatment, other (non-A-T) neu-
rological or neurosurgical condition. Healthy volunteers aged 6–18
years were recruited from local community groups, and excluded if they
had contra-indication to MRI or any neurological, neurosurgical or
other signiﬁcant medical condition. Recruitment ran from January
2015 to September 2016. We aimed to recruit 30 participants with A-T
and 20 controls. Allowing for 20% participant dropout or imaging data
rejection in the A-T group this sample size permits detection of a group
diﬀerence of imaging biomarkers with eﬀect size d = 0.52 with 80%
power and α ≤ 0.05.
2.2. Clinical assessment
A-T Neurological Examination Scale Toolkit (A-TNEST)
(Jackson et al., 2016) was used to quantify neurological disability in the
A-T group. A-TNEST assesses multiple neurological domains (commu-
nication, eye movements, ataxia, movement disorder, power, neuro-
pathy), and neurology-related domains (nutrition, growth). For parti-
cipants who had the A-TNEST administered in the National A-T Clinic
within three months prior to the MRI scan, this score was used,
otherwise the A-TNEST was performed on the day of the study visit
before the scan. The A-TNEST was administered by a fully-qualiﬁed
paediatric neurologist (WW, GC or MP). The total score expressed as a
percentage (where 100% represents no disability) was used in the
analyses. Presence of ATM kinase expression was assessed in lympho-
blastoid cell lines derived from patients by western blotting. ATM ki-
nase activity was assessed using the same patient-derived lympho-
blastoid cell lines by the Taylor laboratory as described previously
(Reiman et al., 2011).
2.3. MRI scanning
MRI scanning was performed on 3T Discovery MR750 (GE
Healthcare, Milwaukee, WI) with 32-channel head coil, without seda-
tion. In addition to standard paediatric MRI preparation, younger par-
ticipants were shown an animation to prepare them for MRI
(Szeszak et al., 2016; McGlashan et al., 2018). The multiparametric MRI
scan protocol included 3D fast spoiled gradient echo T1-weighted
structural MRI (1 mm isotropic resolution, TR = 8.15 ms,
TE = 3.172 ms, TI = 900 ms, FOV = 256 × 256 × 156 mm); EPI-
based axial diﬀusion-weighted imaging (participants were scanned with
at least one of two sequences, a longer protocol for those tolerating the
scan well: TR = 8000 ms, TE = 63 ms, b = 1000s/mm2, 32 separate
non-orthogonal directions, 4 additional b = 0 s/mm2 images acquired,
2 mm isotropic voxel size, whole brain coverage, number of
slices = 66; or shorter protocol if not tolerating the scan well:
TR = 8000 ms, TE = 83 ms, b = 1000s/mm2, 3 orthogonal directions,
0.9 mm × 0.9 mm × 4 mm voxel size, number of averages = 2, whole
brain coverage, number of slices = 30); and in a subset of participants
single voxel MR spectroscopy (Fig. 1) with midline cerebellar voxel
location (Raschke et al., 2018) (MEGA-PRESS with GSH editing,
TR = 2 s, TE = 131 ms and 128 ON and 128 OFF acquisitions; voxel
dimensions x = 50 mm y = 22 mm z = 22 mm; spectral editing using
20 ms sinc-weighted Gaussian pulses at 7.5 ppm (OFF) and 4.54 ppm
(ON)).
2.4. Image processing
T1-weighted images were segmented using Multi-Atlas Label
Propagation with Expectation–Maximisation based reﬁnement (MALP-
EM) algorithm (Ledig et al., 2015; Heckemann et al., 2015), reﬁned
with an additional step to remove residual CSF from cerebellar labels by
classifying all voxels in the cerebellar region with an intensity lower
than a threshold (90th percentile of intensities within the 4th ventricle
label) as CSF. Label volumes were recorded for cerebellar hemispheric
grey matter, cerebellar hemispheric white matter, vermis lobules I–V,
VI–VII and VIII–X, and 4th ventricle (Fig. 1). Cerebellar sub-regional
volumes were combined to give total cerebellar volume. Volumes from
all labels plus additional CSF not covered by the MALP-EM mask (ob-
tained by means of registration and mask propagation with the Colin 27
MNI T1 template (Holmes et al., 1998)) were combined to give total
intracranial volume. Cerebellar and fourth ventricular volumes were
reported as fractional volumes expressed relative to total intracranial
volume.
Apparent Diﬀusion Coeﬃcient (ADC) maps were calculated from
b = 0 and b = 1000 diﬀusion images using the following formula:
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The index i represents each voxel on the image grids and the 106
factor is used to transform values into units of mm2/s. For the shorter
(3-orthogonal direction) diﬀusion acquisitions we directly compute the
ADC map using the b = 0 and averaged b = 1000 images produced
automatically by the MRI scanner. In the case of longer acquisition with
32 directions, correction of eddy current distortions and subject
movement was performed using the eddy_correct tool implemented in
FSL (Jenkinson et al., 2012). We then selected the three b = 1000 vol
corresponding to the orthogonal x, y and z directions and averaged
them to subsequently compute the ADC map as above. Non-linear
10 mm spacing B-spline free-form registrations (Rueckert et al., 1999)
of each ADC map to their corresponding T1-weighted image were
performed using MIRTK (http://github.com/BioMedIA/MIRTK) to ac-
count for inherent spatial distortion of diﬀusion acquisitions. These
were initialised with previously computed linear registrations. Nor-
malised Mutual Information (Studholme et al., 1999) was utilised as
similarity measure in all registrations. In the non-linear case, bending
energy regularisation (Wabha, 1990) with a weight of 0.001 was ap-
plied. MALP-EM segmentation labels were used to extract mean cere-
bellar white matter ADC values. For participants who were able to
tolerate both diﬀusion protocols, the absolute agreement of the cere-
bellar ADC values from the two acquisitions was tested using type A
intraclass correlation. For these participants, the ADC calculated from
the 3-direction acquisition was used in the main analysis.
Unedited MEGA-PRESS OFF spectra were analysed between 4ppm-
0.2 ppm with LCModel (Version 6.3–1H) (Provencher, 2001) using a
basis set simulated with TARQUIN (Wilson et al., 2011) to quantify
total N-Acetyl Aspartate (tNAA), total creatine (tCr), total choline
(tCho), inositol (Ins) and combined glutamine and glutamate (Glx)
(Fig. 1). No relaxation correction was performed. Values for tNAA,
tCho, Ins, and Glx are reported as ratios to tCr, and tNAA is additionally
reported as a ratio to tCho. To allow quantiﬁcation of grey matter and
white matter fractions within the spectroscopy voxel, the voxel was
aligned with the T1-weighted images which were subsequently seg-
mented into grey and white matter components using SPM (http://
www.ﬁl.ion.ucl.ac.uk/spm/software/spm12). Intravoxel grey and
white matter fractions were derived from aligned segmented images
using in-house software.
2.5. Statistical analysis
Statistical analysis was performed using IBM SPSSv23. Normality of
data distribution was assessed by Kolmorgorov-Smirnov test and in-
spection of histograms. Individual cases were excluded from analyses if
the relevant imaging metric was not available due to incomplete ac-
quisition or movement degradation. Group comparisons of distribution
of data were by two tailed independent samples T-Test and correlation
analysis by Pearson correlation unless stated otherwise. Statistical sig-
niﬁcance was deﬁned as α < 0.05, with Bonferroni correction applied
where multiple tests were performed unless stated otherwise.
Multivariate linear regression analysis was performed between MRI-
derived cerebellar measures and A-TNEST. Inclusion of imaging vari-
ables as predictor variables was based on signiﬁcance of α≤0.05 by
univariate regression with the dependent variable (A-TNEST score).
Backwards removal of predictor variables was performed; the histo-
gram of residuals and scatterplots of the standardised residual against
the variable in the adjusted model were inspected to conﬁrm assump-
tions of linearity and homogeneity of the data.
3. Results
The A-T group consisted of 22 children and young people (9 females
Fig. 1. Examples of magnetic resonance spectroscopy data. Examples of segmentation of structural imaging data and spectroscopy data for a participants with
(top row) and without (bottom row) A-T. Left column shows the segmentation labelling for cerebellar substructures (coloured labels) overlaid on the axial T1-
weighted structural image. Note the marked cerebellar atrophy in the participant with A-T. The middle column shows spectroscopy voxel position (rectangle)
overlaid on axial T1-weighted structural image, with corresponding spectrum obtained shown in the right column.
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/ 13 males, median age 10.8 years, range 6.6–17.8 years). Eleven had
no ATM expression, 10 had ATM expression but no kinase activity, and
1 had ATM expression with some residual kinase activity. The control
group comprised 24 healthy individuals (12 females/12 males, median
age 11.2 years, range 6.5–18.4 years). There was no group diﬀerence in
age distribution (t = 0.006. P = 0.995).
A-TNEST data were available for all participants with A-T. Median
A-TNEST score was 64% (range 32%−93%) and correlated with age
(r=−0.548, P= 0.008, Fig. 2A). No group diﬀerence was found in A-
TNEST score for those without ATM expression and those with ATM
expression but no kinase activity (mean 62.9%, s.d.14.9% vs mean
64.5%, s.d. 13.1% respectively, P= 0.863, Independent Samples Mann-
Whitney U Test). The A-TNEST score for the participant with residual
kinase activity was above scores from similarly aged children with no
kinase activity (Fig. 2A).
3.1. Cerebellar volumes are smaller in childhood A-T and show negative
linear correlation with age
Two structural imaging datasets were excluded from the analysis
due to excessive movement. Compared to controls, participants with A-
T had smaller total cerebellar volumes (mean 5.3%, s.d. 0.9% vs mean
8.7%, s.d. 0.5%, t = −15.80, P < 0.005) and larger fractional 4th
ventricular volume (mean 0.19%, s.d. 0.04% vs mean 0.13%, s.d.
0.04%, t = 5.23, P < 0.005). Details of sub-regional fractional cere-
bellar group diﬀerences are given in Table 1.
Negative linear correlation was identiﬁed between age and frac-
tional total cerebellar volumes for the A-T group (r = −0.66,
P = 0.001, Fig. 2B), with positive correlation between these variables
for the control group (r = 0.45, P = 0.026, Fig. 2C). Signiﬁcant dif-
ference was found between regression coeﬃcients for A-T and control
groups (t = −4.48, P < 0.0005). Similar relationships were observed
Fig. 2. Relationship of age to neurological status and cerebellar volumetry. Scatterplots of age and (A) A-TNEST score and (B) fractional total cerebellar volume
for the A-T group, with line ﬁtted for the whole group. Open squares: participants with no ATM expression; Filled squares: participants with ATM expression but no
kinase activity; Star: participant with ATM expression and residual kinase activity. Scatterplot of age and (C) fractional total cerebellar volume and (D) fractional 4th
ventricular volume for A-T group (ﬁlled blue circles) and control group (open green circles) with 95% conﬁdence intervals.
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for fractional cerebellar sub-regional volumes (Supplementary ﬁg. 1A-
E). The relationship between cerebellar volume and age was similar for
A-T participants with absent ATM kinase and those producing non-
functioning ATM kinase (Fig. 2B). Positive correlation was found be-
tween age and fractional 4th ventricular volume for the A-T group
(r = 0.66, P = 0.001) but not the control group (r = 0.34, P = 0.10)
(Fig. 2D), but no group diﬀerence was found between regression coef-
ﬁcients.
3.2. Cerebellar diﬀusion is abnormal in childhood A-T independent of
cerebellar volume and age
Diﬀusion data were available for 19 participants in the A-T group
and all control participants. Cerebellar white matter ADC values were
elevated in the A-T group compared to controls (adjusted means
0.89 × 10−3 mm2 s−1 vs 0.69 × 10−3 mm2 s−1 respectively, ANCOVA
treating diﬀusion-weighted imaging acquisition method as a covariate
of no interest, F = 39.6, P < 0.0005). Cerebellar white matter ADC did
not correlate with age or fractional cerebellar volume for either group.
For the 24 participants who underwent both diﬀusion protocols, the
type A intraclass correlation using an absolute agreement deﬁnition for
cerebellar white matter ADC values was r = 0.75, P = 0.001.
3.3. Cerebellar metabolites are altered in childhood A-T independent of
cerebellar volume and age
Twenty-three participants had good quality cerebellar spectroscopy
data (12 with A-T, mean age 11.5 years, s.d. 4.1 years; 11 without A-T,
mean age 12.5 years, s.d. 2.8 years; no group diﬀerence in age dis-
tribution: t =−0.681. P = 0.50). No diﬀerence was found between A-
T and control groups for the ratio of grey matter to white matter within
the spectroscopy voxel (mean 2.37, s.d. 0.81 vs mean 2.63, s.d. 0.55
respectively, P = 0.091, Independent Samples Mann–Whitney U Test).
Comparison of metabolite ratios using independent samples Mann-
Whitney U test due to non-normal distributions showed signiﬁcant
group diﬀerences (following Bonferroni correction) for tNAA/tCr,
tCho/tCr and tNAA/tCr (Table 2). No signiﬁcant correlations were
identiﬁed between metabolite ratios and age or fractional cerebellar
volume for either the A-T or control groups using Spearman's Rho.
3.4. Cerebellar metabolite ratios correlate with ultrastructural white matter
integrity in childhood A-T and healthy controls
Partial correlation (controlling for age) showed positive correlation
between mean cerebellar white matter ADC and tCho/tCr
(rpartial = 0.68, P < 0.001) and negative correlations with tNAA/tCr
(rpartial =−0.70, P< 0.001), Glx/tCr (rpartial =−0.55, P= 0.008) and
tNAA/tCho (rpartial = −0.66, P = 0.001) (Fig. 3). Positive correlation
between mean cerebellar white matter ADC and Ins/tCr (rpartial = 0.50,
P = 0.018) was not signiﬁcant at the Bonferroni corrected α< 0.0083.
3.5. Fourth ventricular volume correlates with neurological status in
childhood A-T
Results of univariate analysis between cerebellar MRI metrics and
neurological status are shown in Table 3. Three MRI-derived measures
met criterion for inclusion in the regression analysis by univariate
analysis: Fractional 4th ventricular volume (r = −0.53, P = 0.015),
fractional vermis lobules I-V volume (r= 0.46, P= 0.041) and Glx/tCr
(r = 0.59, P = 0.045) (Fig. 4). However, inclusion of Glx/tCr would
have limited the analysis to 12 instead of 20 participants, hence this
variable was excluded. The ﬁnal adjusted model consisted only of
fractional 4th ventricular volume achieving r2adjusted = 0.29, P = 0.015
(unstandardized coeﬃcient B =−17,456, standard error of B = 6523,
95% conﬁdence intervals of B: −31,160 to −3751).
4. Discussion
We identiﬁed age-related profoundly progressive cerebellar volume
loss in children and young people with A-T compared to a small linear
volume increase in healthy individuals. The divergence is most marked
for total cerebellar volume, cerebellar grey matter volumes and su-
perior vermian lobule volumes, but divergence was identiﬁed for all
cerebellar sub-regions. Our observation that 95% conﬁdence intervals
separate towards the end of the ﬁrst decade (Fig. 2C) is consistent with
clinical experience that cerebellar atrophy can be diﬃcult to detect by
visual inspection of diagnostic MRI scans in the ﬁrst few years of life for
children subsequently conﬁrmed to have A-T, and this may contribute
to reported delays in diagnosis of A-T (Devaney et al., 2017). The re-
lationship between cerebellar volume and age was similar for A-T
participants with absent ATM kinase production and those producing
non-functioning ATM kinase.
Despite the linear relationship between age and fractional cerebellar
volume in the A-T group, we did not ﬁnd correlation between fractional
total cerebellar volume and neurological status. We did identify linear
relationships between neurological status and both fractional superior
vermian lobule volumes and fractional fourth ventricular volume in
Table 1
Group comparison of fractional total cerebellar volume, fractional sub-regional cerebellar volumes and fractional 4th ventricular volumes, showing signiﬁcant
diﬀerences between the A-T and healthy control groups using independent samples T-Test. P-values in bold signiﬁcant at Bonferroni corrected α < 0.0071.
A-T group Healthy controls Independent samples T-Test (two tailed)
Mean S.D. Mean S.D. t P
Fractional total cerebellar volume 5.3% 0.9% 8.7% 0.5% −15.80 2.8 × 10−19
Fractional cerebellar hemisphere grey matter volume 3.5% 0.6% 6.0% 0.4% −15.71 3.4 × 10−19
Fractional cerebellar hemisphere white matter volume 1.5% 0.3% 2.1% 0.3% −7.07 1.2 × 10−8
Fractional vermis lobule I-V volume 0.15% 0.03% 0.28% 0.03% −13.73 4.0 × 10−17
Fractional vermis lobule VI-VII volume 0.06% 0.01% 0.11% 0.02% −9.06 2.0 × 10−11
Fractional vermis lobule VIII-X volume 0.10% 0.03% 0.18% 0.02% −11.43 1.8 × 10−14
Fractional 4th ventricular volume 0.19% 0.04% 0.13% 0.04% 5.23 5 × 10−6
S.D. = Standard Deviation.
Table 2
Cerebellar metabolite changes in A-T. Metabolite ratios and statistical testing of
group diﬀerences using Mann–Whitney U test are shown. P–values in bold
signiﬁcant at Bonferroni corrected α-value < 0.0083.
A-T group Healthy controls Mann–Whitney U
Median Range Median Range P
tNAA/tCr 0.99 0.91–1.39 1.11 1.02–1.17 0.002
tCho/tCr 0.30 0.19–0.34 0.27 0.24–0.29 0.007
Ins/tCr 0.65 0.55–0.83 0.62 0.56–0.68 0.118
Glx/tCr 0.48 0.43–0.66 0.54 0.49–0.65 0.037
GSH/tCr 0.11 0.07–0.17 0.12 0.11–0.13 0.118
tNAA/tCho 3.22 2.83–7.35 4.23 3.71–4.58 0.002
tNAA = total N-Acetyl Aspartate, tCr = total creatine, tCho = total choline,
Ins = inositol, Glx = combined glutamine and glutamate, GSH = glutathione.
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univariate analysis of 20 participants, with fractional fourth ventricular
volume surviving as sole predictor variable for neurological status in
multivariate regression analysis. Although it is surprising that cere-
bellar atrophy is not the strongest correlate of neurological dysfunction,
there are potential explanations. The A-TNEST score captures a number
of aspects of neurological function, including domains that are not
speciﬁcally cerebellar, such as extra-pyramidal movement abnormal-
ities. We observed that fractional 4th ventricular volume increased
signiﬁcantly with age in the A-T but not control group, which is likely
to be dominated by atrophy of surrounding cerebellar structures in-
cluding the vermis, cerebellar peduncles, but could also capture subtle
atrophy of the dorsal pons, medulla and midbrain. The combination of
atrophy of these structures may drive neurological symptoms in A-T
explaining the observed correlation with A-TNEST that was not iden-
tiﬁed for fractional total cerebellar volume alone.
We demonstrate signiﬁcant elevation of cerebellar white matter
ADC in childhood A-T and signiﬁcant alterations in cerebellar
metabolite levels, independent of age and cerebellar volume. ADC
provides an index of water mobility, and elevation implies pathological
alterations in tissue ultrastructure or increase tissue water content.
Sahama and colleagues identiﬁed elevated mean diﬀusivity, a diﬀusion
tensor imaging derived metric related to ADC, in the left cerebellar
hemispheric white matter and right superior cerebellar lobule of 11
people with A-T, consistent with our ﬁndings (Sahama et al., 2014b).
This group elegantly demonstrate that loss of white matter integrity
extends beyond the cerebellum, with diﬀusion metrics indicating de-
generation along corticomotor, corticospinal and somatosensory path-
ways (Sahama et al., 2015).
Reduction of cerebellar tNAA ratios was found in the A-T group,
using a voxel including cerebellar grey and white matter. tNAA de-
pletion indexes neuronal dysfunction and death (Geiszler et al., 2018),
and our ﬁndings are consistent with classical descriptions of cerebellar
grey matter pathology in A-T including loss of Purkinje and granular
cells (Clark et al., 2015). We found tNAA ratios correlated inversely
Fig. 3. Correlations between cerebellar neurometabolites and white matter apparent diﬀusion coeﬃcient. Scatterplots showing correlations between cere-
bellar white matter ADC and (A) tNAA/tCr, (B) tCho/tCr, (C) Glx/tCr and (D) tNAA/tCho. A-T group: ﬁlled blue circles; Control group: open green circles.
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with cerebellar white matter ADC indicating that loss of integrity of
cerebellar white matter ultrastructure mirrors neuronal failure, al-
though the causal nature of this association is not clear. The fact that
neither of these measures correlates with cerebellar volume suggests
ultrastructural disruption and neuronal dysfunction are not directly
reﬂected by cerebellar volume changes. Our ﬁnding of cerebellar tNAA
depletion replicates previous ﬁndings in A-T (Lin et al., 2006;
Wallis et al., 2007), and in particular that reduction in cerebellar tNAA
relative to choline distinguishes people with A-T from healthy controls.
(Wallis et al., 2007)
We demonstrate elevated choline ratios childhood A-T (conﬁrming
previous ﬁndings in adult A-T (Wallis et al., 2007)), and show positive
correlation of tCho/tCr with cerebellar white matter ADC. Choline
elevation is a marker of myelin turnover observed in conditions asso-
ciated with demyelination (Bitsch et al., 1999), and our ﬁndings are
consistent with reports of demyelination in A-T (Terplan and
Krauss, 1969). ADC is non-speciﬁc and indexes alterations in multiple
ultrastructural tissue components, but elevated water diﬀusion is re-
cognised in diseases associated with demyelination (Bammer et al.,
2000) which may explain the observed correlation with choline ratios.
Rodent models of A-T demonstrate primary abnormalities of astro-
cytic cells including slow growth, premature senescence and evidence
of oxidative stress (Meshulam et al., 2012; Gosink et al., 1999; Liu et al.,
2005). Our results support astroglial abnormalities in A-T; we found
positive correlation (uncorrected P < 0.05) between inositol and cer-
ebellar white matter ADC, and mean inositol ratios were higher in the
A-T group although the distribution was not signiﬁcantly diﬀerent be-
tween groups. Inositol is elevated in diseases associated with astro-
gliosis with recent evidence suggesting inositol elevation may be a re-
latively late occurrence in the neurodegeneration-related inﬂammatory
cascade (Geiszler et al., 2018). We identiﬁed lower cerebellar combined
glutamine and glutamate (Glx) ratios in the A-T group than controls
(uncorrected P < 0.05) and correlation between cerebellar Glx ratios
and cerebellar white matter ADC, linking glutamine/glutamate meta-
bolism to underlying tissue integrity in A-T. Although Glx concentra-
tions may relate to proportions of grey and white matter in the sampled
volume (Bustillo et al., 2017) this is unlikely to be driving our results as
we found no group diﬀerence in grey:white matter ratio in the spec-
troscopy voxel. Altered glutamate homeostasis co-occurs with glial ac-
tivation in the context of neurodegeneration, with reduced glutamine
and elevated glutamate associated with increased levels of glutamate
dehydrogenase in animal models of progressive neurodegeneration
(Geiszler et al., 2018). Recent work has shown low serum levels of the
glutamate precursor glutamine in ATM-deﬁcient mice, and altered ex-
pression of genes related to glutamine metabolism in ATM-deﬁcient
mice and humans with A-T (Chen et al., 2016). Our ﬁndings support a
role for altered glutamine/glutamate metabolism in A-T but our spec-
troscopy protocol was not designed to resolve glutamine and glutamate
separately limiting our ability to explore pathological mechanisms.
Despite being one of the largest studies using advanced MRI tech-
niques to study childhood A-T, the analysis is limited by small numbers.
The rarity of A-T makes it diﬃcult to assemble large cohorts;
Multicentre and international collaborations are required to allow suf-
ﬁcient numbers for comprehensive statistical analysis, but this will in-
troduce challenges relating to standardisation of multiparametric MRI
protocols (Ashton and Riek, 2013). Our study focusses on cerebellar
imaging metrics, but we acknowledge that pathological changes in the
cerebrum and spinal cord (Clark et al., 2015) could contribute to neu-
rological disability. Another potential limitation is the use of two dif-
fusion protocols, a pragmatic decision made because some participants
could not tolerate the longer 32-direction protocol and were scanned
with a shorter 3-direction protocol. Previous work shows good re-
producibility of ADC values between diﬀerent scanners and protocols,
(Grech-Sollars et al., 2015) and from the 24 participants who under-
went both diﬀusion protocols in our study, we ﬁnd a high intraclass
correlation using an absolute agreement deﬁnition for the cerebellar
white matter ADC values. In addition, we controlled for choice of dif-
fusion protocol in group comparison of ADC values.
Table 3
Univariate analysis between cerebellar MRI metrics and neurological status in
the A-T group. P-values in bold signiﬁcant at uncorrected α < 0.05.
n r P
Fractional total cerebellar volume 20 0.22 0.362
Fractional cerebellar hemisphere grey matter volume 20 0.1 0.572
Fractional cerebellar hemisphere white matter volume 20 0.28 0.233
Fractional vermis lobules I-V volume 20 0.46 0.041
Fractional vermis lobules VI-VII volume 20 0.06 0.802
Fractional vermis lobules VIII-X volume 20 0.38 0.096
Fractional 4th ventricular volume 20 −0.53 0.015
Cerebellar white matter ADC 19 −0.27 0.266
tNAA/tCr 12 0.41* 0.185
tCho/tCr 12 −0.20* 0.526
Ins/tCr 12 0.17* 0.595
Glx/tCr 12 0.59* 0.045
GSH/tCr 12 0.11* 0.742
tNAA/tCho 12 0.36* 0.255
⁎ Spearmann rank correlation used in view of small sample size; elsewhere
Pearson correlation used. ADC = apparent diﬀusion coeﬃcient, tNAA = total
N-Acetyl Aspartate, tCr = total creatine, tCho = total choline, Ins = inositol,
Glx = combined glutamine and glutamate, GSH = glutathione.
Fig. 4. Relationship of neurological status to imaging variables. Scatterplots for the three imaging variable showing correlation with A-TNEST score on uni-
variate analysis for the A-T group; (A) fractional 4th ventricular volume, (B) fractional vermis lobules I-V volumes and (C) Glx/tCr.
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5. Conclusion
Quantitative cerebellar MRI demonstrates diﬀerences between
children with A-T and controls, provide measures of progressive cere-
bellar neurodegeneration, and can provide imaging markers of neuro-
logical status in childhood A-T. Alterations in metabolites known to be
related to neuronal viability, glial activation and myelin turnover relate
to loss of cerebellar white matter ultrastructural integrity in childhood
A-T. As novel treatment strategies are developed and tested
(Chessa et al., 2014), these MRI metrics may be of value in determining
timing and impact of interventions aimed at altering the natural history
of A-T.
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